期刊文献+

婴幼儿神经性肌强直1例

An Infant with Neuromyotonia
下载PDF
导出
摘要 目的:阐述婴幼儿神经性肌强直临床特点,提高对本病的认识。方法:描述神经性肌强直患儿临床症状体征、相关检查及对奥卡西平治疗反应性,长期观察预后情况。结果:本病以肌肉强直运动受限,睡眠中不能放松伴多汗为主要症状,肌电图检查呈强直性放电,目前尚无基因检测指标,生化及头颅影像学检查基本正常。结论:婴幼儿神经性肌强直对小剂量奥卡西平治疗反应良好,治疗前应排除肿瘤性疾病。 Objective: To improve the recognition of neuromyotonia by the clinical characters of a patient. Methods: We described the clinical symptoms and signs, relative examinations, and the responsiv-ity to oral oxcarbazepine, and gave a long-term follow up. Results: Neuromyotonia manifested in clinical symptoms as muscle rigidity limiting to movement and without loose in sleeping accom-panied over sweating, and showed spasticly discharge in electromyography. Now there are no di-agnostic criteria with genes for neuromyotonia. The chemical examination and cephal-icono- graphy are normal. Conclusion: Infant with neuromyotonia responses well to low dose Oxcarbazepine, and neoplastic disease should be ruled out before treatment.
作者 杨广娥
机构地区 安徽省儿童医院
出处 《生理学研究》 2015年第3期15-18,共4页 Journal of Physiology Studies
  • 相关文献

参考文献4

二级参考文献73

  • 1马维亚,徐波,夏春华,汪茜,许贤豪,王湘.获得性神经性肌强直的临床、电生理及其免疫学异常(附并发于肺癌且有肌无力综合征肌电图特征的神经性肌强直1例报告)[J].中国神经免疫学和神经病学杂志,1997,4(2):104-107. 被引量:10
  • 2Ryan DP, Ptacek LJ. Episodic neurological channelopathies [ J ]. Neu- ron, 2010,68(2) :282 -292.
  • 3Maddison P. Neuromyotonia [ J ]. Clin Neurophysiol, 2006,117 ( 10 ) : 2118 -2127.
  • 4Benarroch EE. Potassium channels: brief overview and implications in epilepsy [ J ]. Neurology, 2009,72 ( 7 ) : 664 - 669.
  • 5Grant R, Graus F. Paraneoplastic movement disorder[ J]. Mov Disor- der, 2009,24(12) :1715 - 1724.
  • 6Khasraw M, Posner JB. Neurological complications of systemic cancer [J]. Lancet Neural, 2010,9(12) :1214 -1227.
  • 7Miller TM. Differential diagnosis of myotonic disorder [ J ]. Muscle Nerve, 2008,37(3): 293-299.
  • 8Vincent A. Autoimmune channelopathies : well - established and emer- ging immunotherapy - responsive diseases of the peripheral and central nervous systems[ J]. J Clin Immunol, 2010,30 ( 1 ) :S97 - 102.
  • 9Arimura K, Watanabe O. Immune -mediated neuromyotonia (Isaacs" syndrome) - - clinical aspects and pathomechanism[ J]. Brain Nerve, 2010, 62(4) : 401 -410.
  • 10Heeroma JH, Henneberger C, Rajakulendran S, et al. Episodic ataxia type 1 mutations differentially affect neuronal excitability and transmitter release[ J]. Dis Model Mech, 2009, 2( 11 - 12) : 612 -619.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部